TickerFactsScreenerDevelopers

aTYR PHARMA INC (ATYR) — Operating Income

Annual figures by fiscal year, from SEC filings.

2013: -$19.54M2014: -$23.55M2015: -$47.62M2016: -$57.94M2017: -$47.15M2018: -$32.82M2019: -$22.98M2020: -$15.91M2021: -$34.02M2022: -$46.40M2023: -$54.92M2024: -$67.91M2025: -$77.63M-$77.63M
2013Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$77.63M-14.3%
2024-$67.91M-23.7%
2023-$54.92M-18.3%
2022-$46.40M-36.4%
2021-$34.02M-113.8%
2020-$15.91M+30.8%
2019-$22.98M+30.0%
2018-$32.82M+30.4%
2017-$47.15M+18.6%
2016-$57.94M-21.7%
2015-$47.62M-102.2%
2014-$23.55M-20.5%
2013-$19.54M—